MWM
GILD icon

Moran Wealth Management’s Gilead Sciences GILD Stock Holding History

Moran Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,225
Closed -$351K – 391
2023
Q1 		$351K Sell
4,225
-1,184
-22% -$98.1K 0.01% 317
2022
Q4 		$464K Buy
+5,409
New +$428K 0.02% 302

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Moran Wealth Management's GILD Position: Q2 2023 in Review

Moran Wealth Management sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 4,225 shares — an estimated $351K sold.

Moran Wealth Management first reported a position in GILD in Q4 2022 and held it in 2 quarters. The position peaked at $464K in Q4 2022. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Moran Wealth Management reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • Moran Wealth Management sold 4,225 Gilead Sciences shares in Q2 2023, an estimated $351K.
  • Moran Wealth Management first reported a position in Gilead Sciences in Q4 2022 and held it in 2 quarters.
  • Moran Wealth Management's Gilead Sciences position peaked at $464K in Q4 2022.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Moran Wealth Management's 13F filing for Q2 2023, filed 10 Aug 2023.